Back to results
UnknownPhase 2

Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer

NCT01170143

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Cancer Hospital Affiliated to Fudan University

Shanghai, Shanghai Municipality, China

Contact

Zhimin Shao, Post-doctor

86 21 64175590zhimingshao@yahoo.com
View on ClinicalTrials.gov
Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer — TrialFind